Literature DB >> 34039022

APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population.

Anne Cornelissen1,2, Daniela T Fuller1, Raquel Fernandez1, Xiaoqing Zhao1, Robert Kutys1, Elizabeth Binns-Roemer3, Marco Delsante4,5, Atsushi Sakamoto1, Ka Hyun Paek1, Yu Sato, Rika Kawakami1, Masayuki Mori1, Kenji Kawai1, Teruhiko Yoshida4, Khun Zaw Latt4, Clint L Miller6, Paul S de Vries7, Frank D Kolodgie1, Renu Virmani, Myung Kyun Shin8, Maarten Hoek8, Jurgen Heymann4, Jeffrey B Kopp4, Avi Z Rosenberg4,9, Harry R Davis1, Liang Guo1, Aloke V Finn1,10.   

Abstract

[Figure: see text].

Entities:  

Keywords:  apolipoprotein; cardiovascular disease; coronary artery disease; kidney; plaque, atherosclerotic

Mesh：

Substances：

Year:  2021        PMID： 34039022      PMCID： PMC8651054          DOI： 10.1161/ATVBAHA.120.315788

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   10.514


  64 in total

1.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

2.  Association of APOL1 Risk Alleles With Cardiovascular Disease in Blacks in the Million Veteran Program.

Authors:  Alexander G Bick; Elvis Akwo; Cassianne Robinson-Cohen; Kyung Lee; Julie Lynch; Themistocles L Assimes; Scott DuVall; Todd Edwards; Huaying Fang; S Matthew Freiberg; Ayush Giri; Jennifer E Huffman; Jie Huang; Leland Hull; Rachel L Kember; Derek Klarin; Jennifer S Lee; Michael Levin; Donald R Miller; Pradeep Natarajan; Danish Saleheen; Qing Shao; Yan V Sun; Hua Tang; Otis Wilson; Kyong-Mi Chang; Kelly Cho; John Concato; J Michael Gaziano; Sekar Kathiresan; Christopher J O'Donnell; Daniel J Rader; Philip S Tsao; Peter W Wilson; Adriana M Hung; Scott M Damrauer
Journal:  Circulation       Date:  2019-07-24       Impact factor: 29.690

3.  APOL1 localization in normal kidney and nondiabetic kidney disease.

Authors:  Sethu M Madhavan; John F O'Toole; Martha Konieczkowski; Santhi Ganesan; Leslie A Bruggeman; John R Sedor
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

4.  Eruptive Calcified Nodules as a Potential Mechanism of Acute Coronary Thrombosis and Sudden Death.

Authors:  Sho Torii; Yu Sato; Fumiyuki Otsuka; Frank D Kolodgie; Hiroyuki Jinnouchi; Atsushi Sakamoto; Joohyung Park; Kazuyuki Yahagi; Kenichi Sakakura; Anne Cornelissen; Rika Kawakami; Masayuki Mori; Kenji Kawai; Falone Amoa; Liang Guo; Matthew Kutyna; Raquel Fernandez; Maria E Romero; David Fowler; Aloke V Finn; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2021-04-06       Impact factor: 24.094

5.  Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function.

Authors:  Somenath Datta; Rama Kataria; Jia-Yue Zhang; Savannah Moore; Kaitlyn Petitpas; Adam Mohamed; Nathan Zahler; Martin R Pollak; Opeyemi A Olabisi
Journal:  J Am Soc Nephrol       Date:  2020-07-16       Impact factor: 10.121

6.  APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.

Authors:  Kenneth J Mukamal; Joseph Tremaglio; David J Friedman; Joachim H Ix; Lewis H Kuller; Russell P Tracy; Martin R Pollak
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-03       Impact factor: 8.311

7.  Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort.

Authors:  Julia Kozlitina; Haihong Zhou; Patricia N Brown; Rory J Rohm; Yi Pan; Gulesi Ayanoglu; Xiaoyan Du; Eric Rimmer; Dermot F Reilly; Thomas P Roddy; Doris F Cully; Thomas F Vogt; Daniel Blom; Maarten Hoek
Journal:  J Am Soc Nephrol       Date:  2016-03-22       Impact factor: 10.121

8.  APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice.

Authors:  Jung-Hwa Ryu; Mengyuan Ge; Sandra Merscher; Avi Z Rosenberg; Marco Desante; Hila Roshanravan; Koji Okamoto; Myung K Shin; Maarten Hoek; Alessia Fornoni; Jeffrey B Kopp
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.752

9.  APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults.

Authors:  Orlando M Gutiérrez; Marguerite R Irvin; Ninad S Chaudhary; Mary Cushman; Neil A Zakai; Victor A David; Sophie Limou; Nathalie Pamir; Alex P Reiner; Rakhi P Naik; Michele M Sale; Monika M Safford; Hyacinth I Hyacinth; Suzanne E Judd; Jeffrey B Kopp; Cheryl A Winkler
Journal:  Circ Genom Precis Med       Date:  2018-06

10.  APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.

Authors:  Morgan E Grams; Aditya Surapaneni; Shoshana H Ballew; Lawrence J Appel; Eric Boerwinkle; L Ebony Boulware; Teresa K Chen; Josef Coresh; Mary Cushman; Jasmin Divers; Orlando M Gutiérrez; Marguerite R Irvin; Joachim H Ix; Jeffrey B Kopp; Lewis H Kuller; Carl D Langefeld; Michael S Lipkowitz; Kenneth J Mukamal; Solomon K Musani; Rakhi P Naik; Nicholas M Pajewski; Carmen A Peralta; Adrienne Tin; Christina L Wassel; James G Wilson; Cheryl A Winkler; Bessie A Young; Neil A Zakai; Barry I Freedman
Journal:  J Am Soc Nephrol       Date:  2019-08-05       Impact factor: 14.978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.